Improvement of self-reported wrist/hand pain and functioning outcomes in patients with trigger finger Musculoskeletal Diseases
Conditions
Interventions
Participants will be randomly assigned to one of two intervention groups, relative motion extension orthosis (RME-O) or metacarpophalangeal joint blocking orthosis (MCPJ-BO), during their first occupa
Sponsors
Our Lady’s Hospital, Navan
Health Service Executive
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Adults aged 18 years and over with TF diagnosed by a hand therapist, general practitioner, orthopaedic, or rheumatology doctor, presenting with a grade between 2 and 5 SST of the index, middle, ring, or little finger 2. Able to communicate adequately in English and give informed consent 3. As TF is commonly observed among patients with musculoskeletal disorders and other associated diagnoses such as arthritis, diabetes and carpal tunnel syndrome, these will be included
Exclusion criteria
Exclusion criteria: 1. Those who have previously failed with orthotic intervention, received corticosteroid injections or surgical release of A1 pulley for the symptomatic digit 2. Multiple-digit TF 3. Triggering of the thumb 4. Patients who are pregnant 5. Those patients who are unable to consent or adhere with the intervention for various reasons, such as cognitive, psychological, or physical impairments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient-Rated Wrist and Hand Evaluation (PRWHE), measured at 3, 6, 9, 12 and 15 weeks after randomisation, expressed as the mean total score Updated 12/03/2026 to change final timepoint from 16 weeks to 15 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Grip strength measured using a handheld dynamometer according to standard protocols at 3 and 6 weeks post randomisation 2. Trigger severity objectively assessed using the Stages of Stenosing Tenosynovitis (at 3 and 6 weeks post randomisation) and subjectively via a patient-reported severity scale (at 3, 6, 9, 12 and 15 weeks post randomisation) 3. Trigger frequency measured by the number of trigger events during ten active fists (at 3 and 6 weeks post randomisation) and reported by participants (at 3, 6, 9, 12 and 15 weeks post randomisation) 4. Orthosis wear time documented by patients in a daily diary, recorded on a 10 cm scale representing 10% increments for the entire duration of orthotic use (6 weeks) 5. Orthosis satisfaction assessed on a 0-10 scale, with 0 representing "strongly disagree" and 10 representing "strongly agree" with satisfaction-related statements (at 3 and 6 weeks) Updated 12/03/2026 to change final timepoint from 16 weeks to 15 weeks | — |
Countries
Ireland
Contacts
Public ContactManigandan Chockalingam
Outcome results
None listed